Sign in

CIK 0001127537

  • Non-accelerated filer
  • Smaller reporting company

Pulmonx Corp

Sign in to watch
Ticker
LUNG
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 650-364-0400
Business address
700 CHESAPEAKE DRIVE, REDWOOD CITY, CA, 94063
Former names
PULMONX
  1. 4 Open-market buy Director bought 2,500 shares at $40.00 ($100,000)
  2. 4 Open-market buy Director bought 2,222 shares at $44.12 ($98,035)
  3. 4 Open-market sale President and CEO sold 26,000 shares at an average $42.95 ($1,116,585)
  4. 4 Grant or award Chief Financial Officer acquired 17,600 shares (grant or award)
  5. 4 Grant or award Chief Commercial Officer acquired 17,600 shares (grant or award)
  6. 4 Grant or award Director acquired 2,810 shares (grant or award)
  7. 4 Grant or award Director acquired 2,810 shares (grant or award)
  8. 4 Grant or award General Counsel acquired 17,600 shares (grant or award)
  9. 4 Grant or award President and CEO acquired 45,600 shares (grant or award)
  10. 4 Grant or award Director acquired 2,810 shares (grant or award)
  11. 4 Grant or award Director acquired 2,810 shares (grant or award)
  12. 4 Grant or award Director acquired 2,810 shares (grant or award)
  13. 4 Open-market sale Chief Commercial Officer sold 4,797 shares at an average $40.88 ($196,085)
  14. 4 Open-market sale President and CEO sold 26,000 shares at an average $41.91 ($1,089,530)
  15. 4 Exercise or conversion Chief Commercial Officer acquired 49,428 shares (option exercise)
  16. 4 Open-market sale Chief Commercial Officer sold 4,797 shares at an average $40.70 ($195,247)
  17. 4 Open-market sale Chief Commercial Officer sold 4,797 shares at $43.24 ($207,422)
  18. 4 Open-market sale President and CEO sold 26,000 shares at an average $43.75 ($1,137,556)
  19. 5 Insider Annual Insider Trading Report
  20. 3/A Insider 3/A

Page 10 of 12 · 229 filings